John T. Treace, Chief Executive Offer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 56,509 shares at $18.72 ($1.1M) on 2022-08-23, disclosed to the SEC on 2022-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.72 | 28,000 | $524K | 49.5% |
| 2 | $18.72 | 28,000 | $524K | 49.5% |
| 3 | $18.92 | 509 | $10K | 0.9% |
| Total | $18.72 avg | 56,509 | $1.1M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |